Triple-Hormone-Receptor Agonist Retatrutide for Obesity Weekly retatrutide injections (1 mg12 mg) resulted in weight reductions of 7.217.5% at 24 weeks and 8.724.2% at 48 weeks in subjects with overweight or obesity (without T2DM) in a phase II, double-blind, randomized, placebo-controlled [125]
Because it contains no therapeutic drug, it functions only as a preparation solution
News Release January 11, 2011 Spoilage and labeling errors found with some omega-3 and -6 supplements
These combination data support the hypothesis that dual targeting of amylin receptor and GLP-1 receptor pathways which engage anatomically and mechanistically distinct neural circuits can produce synergistic metabolic outcomes in preclinical and clinical models
2012 Apr;32(14):4790802
Protein Pept Lett 24:190196 Tan J, Huang J, Huang Y, Chen Y (2014) Effects of single amino acid substitution on the biophysical properties and biological activities of an amphipathic -helical antibacterial peptide against Gram-negative bacteria